About Nico Karssemeijer

Nico Karssemeijer is Founder and CEO of ScreenPoint Medical and professor of Computer-Aided Diagnosis at the Radboud University in Nijmegen, The Netherlands. He studied Physics at Delft University of Technology and graduated at the Radboud University in Nijmegen. In 1989 he joined the Department of Radiology of the Radboud University Medical Center in Nijmegen, where he formed a research group in computer aided detection (CAD). Most of his research is devoted to improvement of early detection of breast cancer. He worked as consultant for several successful startups in the San Fransisco Bay area, including R2 Technology and U-systems, and was closely involved in the development of the R2 ImageChecker. He is co-founder of Volpara Health Technologies, Ltd. (Wellington, New Zealand), a company that develops technology for quantitative mammography, and co-founder and consultant of QView Medical (Los Altos, CA) a company that develops automated detection for whole breast unltrasound devices. In 2014 Nico Karssemeijer founded ScreenPoint Medical (Nijmegen, The Netherlands), a company focusing on developing AI technology for early detection and diagnosis of breast cancer.